Skip to main content
. 2023 Jan 23;13:1247. doi: 10.1038/s41598-023-28259-y

Table 1.

Sepsis severity and outcomes of the cohorts with confirmed COVID-19.

Parameter Quebec hospital-wide (wards and ICU) cohort (N = 124)
Age 61.3 ± 1.35 (124)
Sex, female 38.7% (48/124)
Duration of illness before hospital arrival (days) 6.6 ± 0.37 (118)
Hospital stay duration (days) 23.2 ± 2.0 (124)
On Antibiotics 80.0% (96/120)
Non-COVID active infection 35.8% (44/123)
Sampling group Early 61.3% (76 patients); late 38.7% (48 patients)
Existing lung disease 10.5% (13/124)
Existing kidney disease 20.2% (25/124)
Existing heart disease 11.2% (13/124)
Existing liver disease 0.81% (1/124)
Respiratory support at sampling Severe, 43.5% (54/124); intermediate, 22.6% (28/124); moderate, 33.9% (42/124)
SOFA scores 8.02 ± 0.54 (54)
ICU admission 44.4% (55/124)
Mortality (in hospital) 16.1% (20/124)

The mean value ± standard error is presented for numerical variables (total observations in brackets). Categorical variables are presented as % positive observations (relative to total observations). Early samples were taken 1–5 days post admission while late samples 6–20 days post admission. Numbers in brackets are the numbers of patients in each category. Respiratory support definition—severe: required extracorporeal membrane oxygenation (ECMO), Intubation, or Non-invasive ventilation; intermediate: required supplemental oxygen through nasal cannula; moderate: no supplemental oxygen required.